From January 1, 2024 to March 19, 2024, the company has repurchased 74,100 shares, representing 0.21% for ¥242.1 million. With this, the company has completed the repurchase of 1,080,000 shares, representing 2.97% for ¥3,485.1 million under the buyback announced on May 15, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,959 JPY | +0.07% | -3.14% | -9.51% |
Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.51% | 679M | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.